US Stock MarketDetailed Quotes

FDMT 4D Molecular Therapeutics

Watchlist
  • 6.500
  • -0.380-5.52%
Close Dec 13 16:00 ET
  • 6.500
  • 0.0000.00%
Post 16:20 ET
300.48MMarket Cap-2.28P/E (TTM)

4D Molecular Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-99.99%3K
-97.91%5K
-90.60%28K
562.29%20.72M
-101.52%-19K
3,940.80%20.2M
47.53%239K
-75.55%298K
-82.65%3.13M
1,255.43%1.25M
Operating revenue
-99.99%3K
-97.91%5K
-90.60%28K
562.29%20.72M
-101.52%-19K
3,940.80%20.2M
47.53%239K
-75.55%298K
-82.65%3.13M
1,255.43%1.25M
Cost of revenue
Gross profit
Operating expense
49.61%51.14M
31.15%42.46M
25.52%38.16M
18.05%133.59M
22.24%36.63M
26.61%34.18M
13.25%32.38M
10.12%30.4M
26.62%113.16M
20.56%29.97M
Selling and administrative expenses
38.84%12.65M
20.59%10.6M
28.80%10.29M
10.90%36.49M
25.25%10.61M
13.12%9.11M
7.65%8.79M
-2.89%7.99M
17.48%32.91M
15.54%8.47M
-General and administrative expense
38.84%12.65M
20.59%10.6M
28.80%10.29M
10.90%36.49M
25.25%10.61M
13.12%9.11M
7.65%8.79M
-2.89%7.99M
17.48%32.91M
15.54%8.47M
Research and development costs
53.53%38.48M
35.09%31.86M
24.35%27.87M
20.99%97.1M
21.06%26.03M
32.34%25.07M
15.48%23.58M
15.64%22.41M
30.79%80.25M
22.66%21.5M
Operating profit
-265.91%-51.13M
-32.11%-42.46M
-26.67%-38.14M
-2.58%-112.87M
-27.62%-36.65M
47.26%-13.97M
-13.05%-32.14M
-14.07%-30.11M
-54.25%-110.03M
-15.97%-28.72M
Net non-operating interest income expense
88.08%7.29M
200.48%7.55M
298.13%5.75M
374.58%12.21M
227.35%4.38M
387.55%3.88M
638.82%2.51M
1,343.00%1.44M
1,778.10%2.57M
528.85%1.34M
Non-operating interest income
88.08%7.29M
200.48%7.55M
298.13%5.75M
374.58%12.21M
227.35%4.38M
387.55%3.88M
638.82%2.51M
1,343.00%1.44M
1,778.10%2.57M
528.85%1.34M
Other net income (expense)
99.37%-1K
-662.50%-45K
47.37%-10K
-417.14%-181K
-466.67%-11K
-1,855.56%-158K
8K
58.70%-19K
71.07%-35K
142.86%3K
Other non- operating income (expenses)
99.37%-1K
-662.50%-45K
47.37%-10K
-417.14%-181K
-466.67%-11K
-1,855.56%-158K
--8K
58.70%-19K
71.07%-35K
142.86%3K
Income before tax
-327.49%-43.84M
-18.02%-34.95M
-12.97%-32.4M
6.19%-100.84M
-17.91%-32.28M
60.08%-10.26M
-5.45%-29.62M
-8.90%-28.68M
-50.73%-107.49M
-9.15%-27.38M
Income tax
Net income
-327.49%-43.84M
-18.02%-34.95M
-12.97%-32.4M
6.19%-100.84M
-17.91%-32.28M
60.08%-10.26M
-5.45%-29.62M
-8.90%-28.68M
-50.73%-107.49M
-9.15%-27.38M
Net income continuous Operations
-327.49%-43.84M
-18.02%-34.95M
-12.97%-32.4M
6.19%-100.84M
-17.91%-32.28M
60.08%-10.26M
-5.45%-29.62M
-8.90%-28.68M
-50.73%-107.49M
-9.15%-27.38M
Minority interest income
Net income attributable to the parent company
-327.49%-43.84M
-18.02%-34.95M
-12.97%-32.4M
6.19%-100.84M
-17.91%-32.28M
60.08%-10.26M
-5.45%-29.62M
-8.90%-28.68M
-50.73%-107.49M
-9.15%-27.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-327.49%-43.84M
-18.02%-34.95M
-12.97%-32.4M
6.19%-100.84M
-17.91%-32.28M
60.08%-10.26M
-5.45%-29.62M
-8.90%-28.68M
-50.73%-107.49M
-9.15%-27.38M
Basic earnings per share
-229.17%-0.79
18.18%-0.63
25.00%-0.66
22.29%-2.58
8.33%-0.77
69.62%-0.24
11.49%-0.77
-7.32%-0.88
-29.18%-3.32
1.18%-0.84
Diluted earnings per share
-229.17%-0.79
18.18%-0.63
25.00%-0.66
22.29%-2.58
8.33%-0.77
69.62%-0.24
11.49%-0.77
-7.32%-0.88
-29.18%-3.32
1.18%-0.84
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -99.99%3K-97.91%5K-90.60%28K562.29%20.72M-101.52%-19K3,940.80%20.2M47.53%239K-75.55%298K-82.65%3.13M1,255.43%1.25M
Operating revenue -99.99%3K-97.91%5K-90.60%28K562.29%20.72M-101.52%-19K3,940.80%20.2M47.53%239K-75.55%298K-82.65%3.13M1,255.43%1.25M
Cost of revenue
Gross profit
Operating expense 49.61%51.14M31.15%42.46M25.52%38.16M18.05%133.59M22.24%36.63M26.61%34.18M13.25%32.38M10.12%30.4M26.62%113.16M20.56%29.97M
Selling and administrative expenses 38.84%12.65M20.59%10.6M28.80%10.29M10.90%36.49M25.25%10.61M13.12%9.11M7.65%8.79M-2.89%7.99M17.48%32.91M15.54%8.47M
-General and administrative expense 38.84%12.65M20.59%10.6M28.80%10.29M10.90%36.49M25.25%10.61M13.12%9.11M7.65%8.79M-2.89%7.99M17.48%32.91M15.54%8.47M
Research and development costs 53.53%38.48M35.09%31.86M24.35%27.87M20.99%97.1M21.06%26.03M32.34%25.07M15.48%23.58M15.64%22.41M30.79%80.25M22.66%21.5M
Operating profit -265.91%-51.13M-32.11%-42.46M-26.67%-38.14M-2.58%-112.87M-27.62%-36.65M47.26%-13.97M-13.05%-32.14M-14.07%-30.11M-54.25%-110.03M-15.97%-28.72M
Net non-operating interest income expense 88.08%7.29M200.48%7.55M298.13%5.75M374.58%12.21M227.35%4.38M387.55%3.88M638.82%2.51M1,343.00%1.44M1,778.10%2.57M528.85%1.34M
Non-operating interest income 88.08%7.29M200.48%7.55M298.13%5.75M374.58%12.21M227.35%4.38M387.55%3.88M638.82%2.51M1,343.00%1.44M1,778.10%2.57M528.85%1.34M
Other net income (expense) 99.37%-1K-662.50%-45K47.37%-10K-417.14%-181K-466.67%-11K-1,855.56%-158K8K58.70%-19K71.07%-35K142.86%3K
Other non- operating income (expenses) 99.37%-1K-662.50%-45K47.37%-10K-417.14%-181K-466.67%-11K-1,855.56%-158K--8K58.70%-19K71.07%-35K142.86%3K
Income before tax -327.49%-43.84M-18.02%-34.95M-12.97%-32.4M6.19%-100.84M-17.91%-32.28M60.08%-10.26M-5.45%-29.62M-8.90%-28.68M-50.73%-107.49M-9.15%-27.38M
Income tax
Net income -327.49%-43.84M-18.02%-34.95M-12.97%-32.4M6.19%-100.84M-17.91%-32.28M60.08%-10.26M-5.45%-29.62M-8.90%-28.68M-50.73%-107.49M-9.15%-27.38M
Net income continuous Operations -327.49%-43.84M-18.02%-34.95M-12.97%-32.4M6.19%-100.84M-17.91%-32.28M60.08%-10.26M-5.45%-29.62M-8.90%-28.68M-50.73%-107.49M-9.15%-27.38M
Minority interest income
Net income attributable to the parent company -327.49%-43.84M-18.02%-34.95M-12.97%-32.4M6.19%-100.84M-17.91%-32.28M60.08%-10.26M-5.45%-29.62M-8.90%-28.68M-50.73%-107.49M-9.15%-27.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -327.49%-43.84M-18.02%-34.95M-12.97%-32.4M6.19%-100.84M-17.91%-32.28M60.08%-10.26M-5.45%-29.62M-8.90%-28.68M-50.73%-107.49M-9.15%-27.38M
Basic earnings per share -229.17%-0.7918.18%-0.6325.00%-0.6622.29%-2.588.33%-0.7769.62%-0.2411.49%-0.77-7.32%-0.88-29.18%-3.321.18%-0.84
Diluted earnings per share -229.17%-0.7918.18%-0.6325.00%-0.6622.29%-2.588.33%-0.7769.62%-0.2411.49%-0.77-7.32%-0.88-29.18%-3.321.18%-0.84
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data